Rachel Thijssen

9PUBLICATIONS
48CO-AUTHORS
Lasers and quantum electronicsGene expression (incl. microarray and other genome-wide approaches)Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsMolecular, biological, and multi-scale communications
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 25, 2026
Single-cell tracking of the fittest in AML.

|Jan 10, 2025
Single-cell Rapid Capture Hybridization sequencing reliably detects isoform usage and coding mutations in targeted genes.

Hongke Peng, Jafar S Jabbari, Luyi Tian

|Oct 29, 2024
Venetoclax dose escalation rapidly activates a BAFF/BCL-2 survival axis in chronic lymphocytic leukemia.

Meng-Xiao Luo, Tania Tan, Marie Trussart

|Jul 20, 2024
Potential impact of NOTCH1 activation on venetoclax sensitivity in chronic lymphocytic Leukaemia: In vitro insights and clinical implications.

Ming-Yuan Gao, Angela Georgiou, Victor S Lin

|Dec 23, 2022
JAK-STAT signalling shapes the NF-κB response in CLL towards venetoclax sensitivity or resistance via Bcl-XL.

Marco V Haselager, Rachel Thijssen, Danique Bax

|Jun 16, 2022
Single-cell multiomics reveal the scale of multilayered adaptations enabling CLL relapse during venetoclax therapy.

Rachel Thijssen, Luyi Tian, Mary Ann Anderson

Pageof 2

Frequent Collaborators

5 joint publications

Andrew W Roberts

3 joint publications

David C S Huang

3 joint publications

Constantine S Tam

2 joint publications

Mary Ann Anderson